DOP2007000059A - Inhibidores de la adenilato ciclasa soluble - Google Patents
Inhibidores de la adenilato ciclasa solubleInfo
- Publication number
- DOP2007000059A DOP2007000059A DO2007000059A DO2007000059A DOP2007000059A DO P2007000059 A DOP2007000059 A DO P2007000059A DO 2007000059 A DO2007000059 A DO 2007000059A DO 2007000059 A DO2007000059 A DO 2007000059A DO P2007000059 A DOP2007000059 A DO P2007000059A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- adenylate
- cycling
- inhibitors
- soluble
- medicines
- Prior art date
Links
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 title 1
- 230000001351 cycling effect Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006014320A DE102006014320B4 (de) | 2006-03-23 | 2006-03-23 | Inhibitoren der löslichen Adenylatzklase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2007000059A true DOP2007000059A (es) | 2007-09-30 |
Family
ID=38229991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2007000059A DOP2007000059A (es) | 2006-03-23 | 2007-03-23 | Inhibidores de la adenilato ciclasa soluble |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2001847A2 (de) |
| JP (1) | JP2009531319A (de) |
| KR (1) | KR20090007351A (de) |
| CN (1) | CN101448789A (de) |
| AR (1) | AR063661A1 (de) |
| CA (1) | CA2646650A1 (de) |
| DE (1) | DE102006014320B4 (de) |
| DO (1) | DOP2007000059A (de) |
| PE (1) | PE20080012A1 (de) |
| TW (1) | TW200815347A (de) |
| UY (1) | UY30236A1 (de) |
| WO (1) | WO2007107385A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2036906A1 (de) * | 2007-09-05 | 2009-03-18 | Bayer Schering Pharma Aktiengesellschaft | Azaindole als Inhibitoren der löslichen Adenylatzyklase |
| CN108096244B (zh) * | 2018-01-25 | 2020-11-24 | 昆明医科大学 | 1-氢-2-吲哚酮-3-苄基/取代苄基-3-甲酸酯类化合物的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7442805B2 (en) * | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
| US7569604B2 (en) * | 2004-06-22 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Heterocyclic derivatives for modulation of calcium channels |
| DE102004047272A1 (de) * | 2004-09-24 | 2006-04-06 | Schering Ag | Inhibitoren der löslichen Adenylatzyklase |
-
2006
- 2006-03-23 DE DE102006014320A patent/DE102006014320B4/de not_active Expired - Fee Related
-
2007
- 2007-03-22 CN CNA2007800187317A patent/CN101448789A/zh active Pending
- 2007-03-22 EP EP07723654A patent/EP2001847A2/de not_active Withdrawn
- 2007-03-22 KR KR1020087025818A patent/KR20090007351A/ko not_active Withdrawn
- 2007-03-22 WO PCT/EP2007/002708 patent/WO2007107385A2/de not_active Ceased
- 2007-03-22 JP JP2009500787A patent/JP2009531319A/ja active Pending
- 2007-03-22 CA CA002646650A patent/CA2646650A1/en not_active Abandoned
- 2007-03-23 AR ARP070101194A patent/AR063661A1/es unknown
- 2007-03-23 PE PE2007000335A patent/PE20080012A1/es not_active Application Discontinuation
- 2007-03-23 UY UY30236A patent/UY30236A1/es not_active Application Discontinuation
- 2007-03-23 TW TW096110185A patent/TW200815347A/zh unknown
- 2007-03-23 DO DO2007000059A patent/DOP2007000059A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101448789A (zh) | 2009-06-03 |
| WO2007107385A3 (de) | 2007-11-29 |
| CA2646650A1 (en) | 2007-09-27 |
| KR20090007351A (ko) | 2009-01-16 |
| AR063661A1 (es) | 2009-02-11 |
| TW200815347A (en) | 2008-04-01 |
| DE102006014320B4 (de) | 2009-01-22 |
| UY30236A1 (es) | 2007-10-31 |
| DE102006014320A1 (de) | 2007-09-27 |
| EP2001847A2 (de) | 2008-12-17 |
| PE20080012A1 (es) | 2008-04-03 |
| JP2009531319A (ja) | 2009-09-03 |
| WO2007107385A2 (de) | 2007-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR11861A (es) | Compuestos organicos | |
| NO20090295L (no) | Substituerte heteroarylderivater | |
| UA107951C2 (xx) | Похідні імідазопіридину як інгібітори jak | |
| EA201070519A1 (ru) | Соединения тропана | |
| CL2007002316A1 (es) | Compuestos derivados de pirimidina, inhibidores de pi3k; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades proliferativas como cancer. | |
| NO20083630L (no) | Nye pyridinderivater | |
| CR20120634A (es) | Derivados de heteroaril imidazolona como inhibidores de jak | |
| UY31673A1 (es) | "derivados heterocíclicos de urea y métodos de uso de los mismos-211" | |
| ATE553104T1 (de) | Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer | |
| EA201170832A1 (ru) | Пуриновые соединения | |
| GT200800251A (es) | Nitrilos espirociclicos como inhibidores de proteasa | |
| EA201070327A1 (ru) | Катехоламиновые производные и их пролекарства | |
| EA201000614A1 (ru) | Производные пурина как лиганды аденозинового рецептора а | |
| EA201071224A1 (ru) | Ингибиторы limk2, композиции, содержащие их, и способы их применения | |
| BRPI0911772A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
| EA201000069A1 (ru) | Новые гербициды | |
| ATE445593T1 (de) | Acetylenderivate | |
| CR9058A (es) | Derivados de indol como inhibidores de la adenilato ciclasa soluble | |
| PA8657801A1 (es) | Aminalcoholes triciclicos, procedimientos para su preparacion | |
| UY30424A1 (es) | Derivados de quinolina, su preparacion, su uso y medicamentos que comprenden los mismos. | |
| UY28917A1 (es) | Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico | |
| EA200870148A1 (ru) | Производные сулиндака, их применение и получение | |
| UY30235A1 (es) | Inhibidores de la adenilato ciclasa soluble | |
| ECSP078024A (es) | Inhibidores de la adenilato ciclasa soluble | |
| NO20091386L (no) | Fenyloksyanilinderivater |